Literature DB >> 19109438

Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.

Badam Enkhmandakh1, Aleksandr V Makeyev, Lkhamsuren Erdenechimeg, Frank H Ruddle, Nyam-Osor Chimge, Maria Isabel Tussie-Luna, Ananda L Roy, Dashzeveg Bayarsaihan.   

Abstract

GTF2I and GTF2IRD1 encoding the multifunctional transcription factors TFII-I and BEN are clustered at the 7q11.23 region hemizygously deleted in Williams-Beuren syndrome (WBS), a complex multisystemic neurodevelopmental disorder. Although the biochemical properties of TFII-I family transcription factors have been studied in depth, little is known about the specialized contributions of these factors in pathways required for proper embryonic development. Here, we show that homozygous loss of either Gtf2ird1 or Gtf2i function results in multiple phenotypic manifestations, including embryonic lethality; brain hemorrhage; and vasculogenic, craniofacial, and neural tube defects in mice. Further analyses suggest that embryonic lethality may be attributable to defects in yolk sac vasculogenesis and angiogenesis. Microarray data indicate that the Gtf2ird1 homozygous phenotype is mainly caused by an impairment of the genes involved in the TGFbetaRII/Alk1/Smad5 signal transduction pathway. The effect of Gtf2i inactivation on this pathway is less prominent, but downregulation of the endothelial growth factor receptor-2 gene, resulting in the deterioration of vascular signaling, most likely exacerbates the severity of the Gtf2i mutant phenotype. A subset of Gtf2ird1 and Gtf2i heterozygotes displayed microcephaly, retarded growth, and skeletal and craniofacial defects, therefore showing that haploinsufficiency of TFII-I proteins causes various developmental anomalies that are often associated with WBS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109438      PMCID: PMC2629217          DOI: 10.1073/pnas.0811531106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The challenges of translating knockout phenotypes into gene function.

Authors:  J N Ihle
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.

Authors:  Dashzeveg Bayarsaihan; Judit Dunai; John M Greally; Kazuhiko Kawasaki; Kenta Sumiyama; Badam Enkhmandakh; Nobuyoshi Shimizu; Frank H Ruddle
Journal:  Genomics       Date:  2002-01       Impact factor: 5.736

Review 4.  Transgenic mouse models in angiogenesis and cardiovascular disease.

Authors:  P Carmeliet; D Collen
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

5.  Characterization of general transcription factor 3, a transcription factor involved in slow muscle-specific gene expression.

Authors:  Detlef Vullhorst; Andres Buonanno
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

Review 6.  Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.

Authors:  M J Goumans; C Mummery
Journal:  Int J Dev Biol       Date:  2000-04       Impact factor: 2.203

7.  Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains.

Authors:  D Bayarsaihan; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 8.  Williams syndrome and related disorders.

Authors:  C A Morris; C B Mervis
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

9.  Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.

Authors:  J Larsson; M J Goumans; L J Sjöstrand; M A van Rooijen; D Ward; P Levéen; X Xu; P ten Dijke; C L Mummery; S Karlsson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

10.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.

Authors:  S P Oh; T Seki; K A Goss; T Imamura; Y Yi; P K Donahoe; L Li; K Miyazono; P ten Dijke; S Kim; E Li
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

View more
  55 in total

1.  The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.

Authors:  Paulina Carmona-Mora; Jocelyn Widagdo; Florence Tomasetig; Cesar P Canales; Yeojoon Cha; Wei Lee; Abdullah Alshawaf; Mirella Dottori; Renee M Whan; Edna C Hardeman; Stephen J Palmer
Journal:  Hum Genet       Date:  2015-08-15       Impact factor: 4.132

Review 2.  Role of helix-loop-helix proteins during differentiation of erythroid cells.

Authors:  Archana Anantharaman; I-Ju Lin; Joeva Barrow; Shermi Y Liang; Jude Masannat; John Strouboulis; Suming Huang; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

3.  A 1.3-mb 7q11.23 atypical deletion identified in a cohort of patients with williams-beuren syndrome.

Authors:  L M Delgado; M Gutierrez; B Augello; C Fusco; L Micale; G Merla; E A Pastene
Journal:  Mol Syndromol       Date:  2013-02-28

4.  An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.

Authors:  Giovanni Battista Ferrero; Cédric Howald; Lucia Micale; Elisa Biamino; Bartolomeo Augello; Carmela Fusco; Maria Giuseppina Turturo; Serena Forzano; Alexandre Reymond; Giuseppe Merla
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

5.  Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.

Authors:  Maria B Lazebnik; Maria Isabel Tussie-Luna; Philip W Hinds; Ananda L Roy
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

Review 6.  Copy number variants at Williams-Beuren syndrome 7q11.23 region.

Authors:  Giuseppe Merla; Nicola Brunetti-Pierri; Lucia Micale; Carmela Fusco
Journal:  Hum Genet       Date:  2010-05-01       Impact factor: 4.132

7.  Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.

Authors:  Stephen J Palmer; Nicole Santucci; Jocelyn Widagdo; Sara J Bontempo; Kylie M Taylor; Enoch S E Tay; Jeff Hook; Frances Lemckert; Peter W Gunning; Edna C Hardeman
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

8.  Evolution of general transcription factors.

Authors:  K V Gunbin; A Ruvinsky
Journal:  J Mol Evol       Date:  2012-12-11       Impact factor: 2.395

9.  Essential role of the N-terminal region of TFII-I in viability and behavior.

Authors:  Jaume Lucena; Susana Pezzi; Ester Aso; Maria C Valero; Candelas Carreiro; Pierre Dubus; Adriana Sampaio; Maria Segura; Isabel Barthelemy; Marc Y Zindel; Nuno Sousa; José L Barbero; Rafael Maldonado; Luis A Pérez-Jurado; Victoria Campuzano
Journal:  BMC Med Genet       Date:  2010-04-19       Impact factor: 2.103

10.  Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.

Authors:  Iwona Fijalkowska; Deva Sharma; Carol J Bult; Sonye K Danoff
Journal:  BMC Res Notes       Date:  2010-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.